NDC 63850-0107-01 - Everolimus
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63850-0107
- Requested NDC
- 63850-0107-01
- Package NDCs from labels
- 63850-0107-1, 63850-0107-2, 63850-0107-3, 63850-0107-01
- Manufacturer
- Natco Pharma Limited | Natco Pharma Limited-Pharma Division
- Effective date
- 2025-10-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Everolimus - Natco Pharma Limited | Natco Pharma Limited-Pharma Division | Natco Pharma Limited | Natco Pharma Limited-Pharma Division | 2025-10-14 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63850-0107-1 | Everolimus | 10 in 1 BLISTER PACK | TABLET | 10 | 5 | |
| 63850-0107-2 | Everolimus | 60 in 1 CARTON | TABLET | 60 | 5 | |
| 63850-0107-3 | Everolimus | 60 in 1 BOTTLE | TABLET | 60 | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| everolimus | EVEROLIMUS | Novugen Pharma (USA) LLC. | 67e62e26-448d-46ec-b5a1-00dc1b5e26c6 | 2026-03-10 | Warnings, Adverse reactions | 9HW64Q8G6G |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-03-06 | Warnings | 3NXW29V3WO |
| everolimus | EVEROLIMUS | Aurobindo Pharma Limited | 43ef3c29-0e25-4fdd-aea1-06a20af9bbab | 2026-02-26 | Boxed warning, Warnings, Adverse reactions | 2056895 977427 977434 977438 9HW64Q8G6G |
| Discount Drug Mart Eye Drops Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Discount Drug Mart | f7fd53be-e501-d97f-e053-6394a90ad409 | 2025-12-30 | Warnings | 3NXW29V3WO |
| Exchange Select Artificial Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Army and Air Force Exchange Service | 9e478343-8ae7-823e-e053-2995a90a84ed | 2025-12-30 | Warnings | 3NXW29V3WO |
| DG Health Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYPROPYLENE GLYCOL 400 | Dolgencorp LLC | 9cb20c3b-bf6d-8c7c-e053-2995a90aa485 | 2025-12-30 | Warnings | 3NXW29V3WO |
| Core Values Eye Drops Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Liberty Procurement Co. Inc. | f8285f68-c40c-19a8-e053-6394a90aacad | 2025-12-30 | Warnings | 3NXW29V3WO |
| Harris Teeter Eye Drops Artificial Tears | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Harris Teeter, LLC. | f82957d9-c4ad-a914-e053-6294a90aac50 | 2025-12-30 | Warnings | 3NXW29V3WO |
| CVS Gentle Tears | DEXTRAN 70, HYPROMELLOSE | CVS Pharmacy, Inc. | 9b1ea0eb-c34f-6603-e053-2995a90a6a95 | 2025-12-30 | Warnings | 3NXW29V3WO |
| Everolimus | EVEROLIMUS | Ascend Laboratories, LLC | 2693c497-a70b-4d00-b6db-602c872e5bed | 2025-12-19 | Boxed warning, Warnings, Adverse reactions | 2056895 977427 977434 977438 9HW64Q8G6G |
| Artificial Tears | GLYCERIN | Geri-Care Pharmaceuticals, Corp | 7cc437e3-bad9-59be-e053-2991aa0a1da3 | 2025-12-19 | Warnings | 3NXW29V3WO |
| Artificial Tears | GLYCERIN | NuCare Pharmaceuticals,Inc. | 97a3d8e2-b2c0-3f5d-e053-2a95a90ac49d | 2025-12-15 | Warnings | 3NXW29V3WO |
| Everolimus | EVEROLIMUS | Natco Pharma Limited | d44998bb-5deb-4ee7-a0a5-979fe3f49557 | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | ANDA205432 63850-0107-3 63850-0107-1 63850-0063-2 63850-0062-6 63850-0062-2 63850-0063-3 63850-0107-2 63850-0064-2 63850-0063-6 63850-0062-3 63850-0064-6 63850-0063 63850-0107 63850-0062 63850-0064 63850010701 2056895 977427 977434 977438 111c2e93-390f-40c6-a626-6aa45878a801 d44998bb-5deb-4ee7-a0a5-979fe3f49557 9HW64Q8G6G |
| Everolimus | EVEROLIMUS | Breckenridge Pharmaceutical, Inc. | 01f7b5fb-be0d-4adf-acd2-6899018de966 | 2025-09-05 | Warnings, Adverse reactions | 9HW64Q8G6G |
| Everolimus | EVEROLIMUS | Biocon Pharma Inc. | 435da284-ef0e-ca90-e0db-bab9382922e0 | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | 2056895 977427 977434 977438 9HW64Q8G6G |
| EVEROLIMUS | EVEROLIMUS | Biocon Pharma Inc. | 5fb55800-f322-6bb6-9dde-622925ef28bd | 2025-03-21 | Warnings, Adverse reactions | 9HW64Q8G6G |
| Advanced Eye Relief/ Redness Maximum Relief | NAPHAZOLINE HYDROCHLORIDE AND HYPROMELLOSE | Bausch & Lomb Incorporated | 3c11285a-7e86-4b47-b1ee-e7d59858087d | 2024-09-25 | Warnings | 3NXW29V3WO |
| Everolimus | EVEROLIMUS | Hikma Pharmaceuticals USA Inc. | cf2dd54b-7a1d-4401-9a01-75e68235e433 | 2024-09-03 | Boxed warning, Warnings, Adverse reactions | 2056895 977427 977434 977438 9HW64Q8G6G |
| Multi-Phenolic | MANNOSE, 5-HYDROXYTRYPTOPHAN, ACETALDEHYDE, ACETYLCHOLINE CHLORIDE, ASCORBICUM ACIDUM, ASPARTAME, BUTYLATED HYDROXYTOLUENE, CAFFEIC ACID, CANDIDA ALBICANS, CINNAMIC ACID, CONIFERYL ALCOHOL, COUMARINUM, DOPAMINE HYDROCHLORIDE, ESTRADIOL, GABA (GAMMA-AMINOBUTYRIC ACID), GALLICUM ACIDUM, HISTAMINUM HYDROCHLORICUM, HYDROCORTISONE, INDOLUM, L-DOPA, L-PHENYLALANINE, MELATONIN, MENADIONE, NOREPINEPHRINE (BITARTRATE), PETROSELINUM CRISPUM, PHENYL ISOTHIOCYANATE, PIPERINE, PROGESTERONE, PYRROLE, QUERCETIN, | Energique, Inc. | 492b412a-01cc-48f2-bcdc-6fffcc651963 | 2024-08-23 | Warnings | 1P9D0Z171K |
| EVEROLIMUS | EVEROLIMUS | NorthStar RxLLC | 5cfca904-b75c-5a39-8cb9-b99bb421bceb | 2024-08-02 | Warnings, Adverse reactions | 9HW64Q8G6G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.